We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about the common and serious side effects of Jakafi (ruxolitinib), how to manage them, and when to seek medical help. Essential information for patients in India.

Jakafi, with its active ingredient ruxolitinib, is a prescription medication used to manage certain blood cancers like myelofibrosis and polycythemia vera, as well as graft-versus-host disease (GVHD). While it offers significant therapeutic benefits, like any potent medication, it can cause side effects. This comprehensive guide aims to provide clear, practical information for Indian readers about the potential side effects of Jakafi, how to manage them, and when to seek medical attention.
Jakafi belongs to a class of drugs known as kinase inhibitors. It works by targeting specific pathways in the body that contribute to the overproduction of blood cells and inflammation associated with certain conditions. By inhibiting these pathways, Jakafi helps to control the disease and alleviate symptoms.
While individual experiences may vary, several common side effects have been reported by patients taking Jakafi. These are often mild and may resolve on their own or with simple management strategies. It's important to discuss any persistent or bothersome side effects with your doctor.
Many of the side effects associated with Jakafi are mild and can be managed effectively. Here are some common mild side effects and tips for coping:
While less common, Jakafi can cause serious side effects that require immediate medical attention. It is crucial to be aware of these potential risks and to contact your doctor or emergency services if you experience any of the following:
It is vital to maintain open communication with your healthcare provider. Contact your doctor right away if you experience:
In case of life-threatening side effects or a medical emergency, call 911 or your local emergency number immediately.
Before starting Jakafi, and regularly throughout your treatment, your doctor will perform blood tests, including a complete blood count (CBC). This monitoring is crucial to check for changes in your blood cell levels (red blood cells, white blood cells, and platelets) and to detect potential side effects early. The frequency of these tests will depend on your individual response and dosage.
It is not known if Jakafi passes into breast milk. However, due to the risk of serious blood-related side effects, including thrombocytopenia and anemia, it is generally recommended that you do not breastfeed your child while taking Jakafi and for a period after your last dose, as advised by your doctor. Discuss your breastfeeding plans with your healthcare provider.
When taking Jakafi, remember:
Jakafi is an important medication for managing specific blood disorders and GVHD. While side effects can occur, understanding them and knowing how to manage them, along with regular medical monitoring, can help ensure the best possible outcomes. Always prioritize open communication with your healthcare team to navigate your treatment safely and effectively.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.

Sleeping tablets can help manage insomnia and sleep disorders when used correctly. This guide explains types, benefits, risks, and safe usage tips for better sleep health.
April 11, 2026
Explore the short-term and long-term effects of Adderall on the brain, including its uses, side effects, risks of misuse, and the importance of medical supervision for safe and effective treatment.
April 1, 2026

Curious if Pepto-Bismol can help your stomach after drinking? We explore the potential risks and what the research says about mixing Pepto-Bismol and alcohol, plus safer alternatives for hangover relief.
April 1, 2026